Regulatory T cells in peripheral blood of patients with mixed connective tissue disease
- 1 January 2006
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 35 (4) , 300-304
- https://doi.org/10.1080/03009740600709790
Abstract
To determine the percentage and absolute number of CD4+ regulatory T-cells (Treg) in 48 patients with mixed connective tissue disease (MCTD). Data were classified on the basis of the stage of the disease: 17 patients were in the active stage and 31 in the inactive stage. The absolute number of CD4+/intracellular interleukin-10+ (IL-10+) and CD4+CD25+high Treg cells was determined by flow cytometry. The percentage of CD4+CD25+high suppressor T-cells was determined on the basis of Foxp3 expression. The percentage and the absolute number of CD4+CD25+high Treg cells were lower in patients than in healthy controls (p<0.04), and were further decreased in patients with active MCTD and were lower than in the inactive stage (p<0.01). There was an increase in the percentage and absolute number of CD4+IL-10+ Treg cells in patients with MCTD compared to the healthy controls (p<0.02). The percentage of CD4+IL-10+ Treg cells was higher in the active stage of MCTD than in the inactive stage of the disease (p<0.005). However, we did not find any significant difference in the absolute number of CD4+IL-10+ Treg cells between the patients in the active and inactive stages of MCTD. Our results suggest that the decrease in the number of CD4+CD25+high Treg cells in an important factor in the immunoregulatory disturbance in patients with MCTD. We suggest that the increase in the number of CD4+IL-10+ Treg cells is a compensatory mechanism aiming to restore the balance between type 1 and type 2 cytokines in MCTD.Keywords
This publication has 21 references indexed in Scilit:
- Circulating and thymic CD4+ CD25+ T regulatory cells in myasthenia gravis: effect of immunosuppressive treatmentImmunology, 2005
- Single cell analysis shows decreasing FoxP3 and TGFβ1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetesThe Journal of Experimental Medicine, 2005
- MRL/Mp CD4+,CD25− T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: A novel defect of T cell regulation in systemic lupus erythematosusArthritis & Rheumatism, 2005
- Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD)Rheumatology, 2005
- CD4+CD25high regulatory T cells in human autoimmune diabetesJournal of Autoimmunity, 2005
- An elevated level of IL-10- and TGF?-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritisClinical Rheumatology, 2004
- In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing CytokinesThe Journal of Experimental Medicine, 2002
- Longitudinal study of interleukin-10, tumor necrosis factor- α, anti-U1-snRNP antibody levels and disease activity in patients with mixed connective tissue diseaseScandinavian Journal of Rheumatology, 2001
- Increased Serum Levels of Immunoglobulins, C-reactive Protein, Type 1 and Type 2 Cytokines in Patients with Mixed Connective Tissue DiseaseJournal of Autoimmunity, 1998
- Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosusArthritis & Rheumatism, 1989